Javier Pagonabarraga

Connectome-based brain fingerprints predict early cognitive decline in Parkinson's patients with minor hallucinations

The paper uses connectome-based brain fingerprinting to identify early cognitive decline markers in Parkinson's patients with minor hallucinations using resting-state fMRI.

Plasmatic immune extracellular vesicle profiles identify prodromal and early stages of Parkinson's disease

The paper identifies distinct plasmatic immune extracellular vesicle profiles associated with different stages of neurodegenerative proteinopathies, with the highest diagnostic utility for prodromal REM sleep behavior disorder.

A Novel Susceptibility Locus in NFASC Highlights Oligodendrocytes and Myelination in Progressive Supranuclear Palsy Pathology

The paper performs a GWAS on PSP in the Iberian population, replicates known risk variants, and identifies a novel locus in NFASC/CNTN2 associated with oligodendrocyte and myelination processes.

Theta oscillations and minor hallucinations in Parkinson's disease reveal decrease in frontal lobe functions and later cognitive decline

The paper investigates if minor hallucinations in Parkinson's disease are linked to frontal theta oscillations and cognitive decline, finding a correlation between these factors and later cognitive impairment.

Neural signatures of predictive language processing in Parkinson's disease with and without mild cognitive impairment

The paper investigates neural signatures of predictive language processing in Parkinson's disease patients with and without mild cognitive impairment using ERP measurements.

Sensorimotor hallucinationsin Parkinson's disease

This study uses robotics to induce hallucinations in Parkinson's disease patients and identifies a disrupted neural network associated with sensorimotor hallucinations.

The genetic architecture of Parkinson disease in Spain: characterizing population-specific risk, differential haplotype structures, and providing etiologic insight

This study conducts a GWAS of Parkinson disease in Spain, identifies a novel population-specific signal at PARK2 associated with age-at-onset, and highlights genetic substructure for future fine-mapping.